Wordt geladen...

Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer

PURPOSE: We previously found that the risk of invasive breast cancer varied according to the progestagen component of combined postmenopausal hormone therapy (CHT): progesterone, dydrogesterone, or other progestagens. We conducted the present study to assess how these CHTs were associated with histo...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Fournier, Agnès, Fabre, Alban, Mesrine, Sylvie, Boutron-Ruault, Marie-Christine, Berrino, Franco, Clavel-Chapelon, Françoise
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Clinical Oncology 2008
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2346534/
https://ncbi.nlm.nih.gov/pubmed/18323549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.13.4338
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!